RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Hongli Yu(Liuzhou General Hospital), Qiang Zhu(Shandong University), Yang Yao(University of Science and Technology of China), Yuping Bai(Chengdu University of Traditional Chinese Medicine), Xiaoyu Xie(Nanjing University of Science and Technology), Yuemin Feng(Shandong Provincial Hospital)
Cited by 42
Related Papers
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2021|708
Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol
|Cell Research|2018|123
Dynamic APACHE II Score to Predict the Outcome of Intensive Care Unit Patients
|Frontiers in Medicine|2022|100
Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis
|Therapeutic Advances in Respiratory Disease|2019|81
Interleukin-6 and Diabetic Retinopathy: A Systematic Review and Meta-Analysis
|Current Eye Research|2019|73